Student Pharmacist Non-Pharmacological Intervention on Type 2 Diabetes Management in Older Asian Adult Populations

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 28, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how student pharmacists can help manage type 2 diabetes in older adults who are Asian or of Asian descent. Specifically, it aims to see if non-drug approaches, like lifestyle changes and education, can improve blood sugar levels in people over 50 who have uncontrolled diabetes. The goal is to expand the role of student pharmacists in healthcare and find new ways to support patients in managing their diabetes effectively.

To participate in this study, you need to be at least 50 years old, identify as Asian or of Asian descent, and have been diagnosed with type 2 diabetes that is not well controlled (with an A1C level over 7.0%). You should also be regularly monitoring your blood sugar as your doctor has directed. Unfortunately, if you are under 50, have a different type of diabetes, or are taking certain medications that can affect blood sugar, you won’t be eligible. If you join the study, you can expect to receive support from student pharmacists, who will provide guidance on managing your diabetes through non-drug methods. This is an exciting opportunity to be part of a program that aims to improve diabetes care in the community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults ≥ 50 years old
• • Asian or Asian-descent
• • Diagnosed with T2DM
• • A1C \>7.0% (uncontrolled)
• • Take blood glucose measurements as prescribed by their physician, or consistently (defined as missing no more than 1 reading from their regular routine).
• Exclusion Criteria:
• • Age \< 50 years old
• • Not diagnosed with type 2 diabetes, or have diagnoses such as type 1 diabetes, gestational diabetes, or medication induced diabetes
• • Patients that are on medications that affect glycemic control
• • Corticosteroids
• • First-generation antipsychotics (e.g. chlorpromazine, perphenazine, phenothiazines)
• • Immunosuppressants (e.g. tacrolimus, cyclosporine)
• • Experiencing acute disease states
• • Recent surgery/hospitalized within the last 3 months
• • Active infections
• • Non-adherence to blood glucose monitoring (defined as missing \> 1 reading from their regular routine or not taking readings as prescribed by their doctor)
• • Patients with late stage T2DM requiring insulin therapy
• • Diagnosed with cancer, end-stage renal disease, end-stage liver disease
• • Received any organ transplant